3-D-printed drug carrier shows promise; Swiss, South Korean pharma companies sign drug delivery pact;

> South Korean researchers announced positive results from their test of a 3-D-printed drug and cell carrier for local and sustained delivery of cyclosporine A. "The improved load-bearing capacity of the combined microsphere and hydrogel system, and its ability to maintain its integrity and shape during the implantation period, helped to deliver a sustained CsA release, preventing the acceleration of the secretion of cytokines related to immune rejection," said Dr. Dong-Woo Cho of the Department of Mechanical Engineering at Pohang University of Science and Technology. More

> Switzerland's Ferring Pharmaceuticals announced that it has a signed a deal with South Korea's CTCBIO Inc. to acquire the rights to a novel oral drug delivery technology. Release

> Not-for-profit preclinical research institute CBSET said its study found that the use of Cardiovascular Systems' Diamondback 360 orbital atherectomy device improved drug absorption in calcified peripheral arteries. Release

Suggested Articles

Nanoform Finland tapped Quotient Sciences to help run the first in-human trial of a drug developed using its 'nanoforming' technology later this year.

Swiss scientists are using ultrasound to trap and deliver drugs in the brain, a non-invasive delivery method that could help target tumors, too.

Alexion's 100 mg/ml Ultomiris formulation is expected to slash infusion times by about 60% and bodes well for a planned subcutaneous version, too.